How has been the historical performance of Hemo Organic?

Answer:The historical performance of Hemo Organic shows a significant increase in net sales, rising from 0.02 Cr in March 2024 to 2.41 Cr in March 2025. This marks a notable recovery from previous years where sales were minimal, with figures like 0.00 Cr in March 2023 and only 0.01 Cr in March 2022. Total operating income followed a similar trend, increasing to 2.41 Cr in March 2025 from 0.02 Cr in March 2024. However, total expenditure also rose sharply to 2.46 Cr in March 2025 from 0.27 Cr in March 2024, leading to an operating profit (PBDIT) of 0.02 Cr in March 2025, a recovery from a loss of 0.25 Cr in March 2024. Profit before tax improved to 0.03 Cr in March 2025, compared to a loss of 0.26 Cr in March 2024, and net profit turned positive at 0.16 Cr in March 2025, reversing a loss of 0.26 Cr in the previous year. The earnings per share (EPS) also reflected this positive trend, moving to 0.46 in March 2025 from -0.75 in March 2024. The PAT margin improved significantly to 6.64% in March 2025, compared to -1300.0% in March 2024, indicating a strong turnaround in profitability.

Breakdown:
Hemo Organic's financial performance has shown a remarkable turnaround, particularly in the fiscal year ending March 2025. The company achieved net sales of 2.41 Cr, a significant increase from the previous year's 0.02 Cr, indicating a strong recovery in revenue generation. Total operating income mirrored this growth, reaching 2.41 Cr, while total expenditure also increased to 2.46 Cr, leading to a slight operating profit of 0.02 Cr. The profit before tax improved to 0.03 Cr, and the net profit turned positive at 0.16 Cr, a stark contrast to the losses reported in the prior year. This positive trend is further highlighted by the earnings per share, which rose to 0.46 from a negative 0.75, and the PAT margin improved to 6.64%, showcasing a significant recovery in profitability for Hemo Organic.